
James R Wilentz, MD
About Me
Language
English
Position
ASSOCIATE CLINICAL PROFESSOR | Medicine, Cardiology, ASSOCIATE CLINICAL PROFESSOR | Global Health and Health Systems Design
Research Topics
Global Health, Stroke
Clinical Focus
- Angiography
- Aortic Insufficiency
- Aortic Regurgitation
- Aortic Stenosis
- Atherectomy coronary vessel
- Atherectomy/Angioplasty Of Noncoronary Vessel
- Atrial Fibrillation
- Atrioventricular Septal Defect
- Bacterial Endocarditis
- Bifurcation Stent
- Cardiac Catherization
- Cardiomyopathy
- Cardiovascular Disease
- Carotid Artery Endarterectomy
- Chest Pain
- Chronic Total Occlusion
- Coronary Angioplasty
- Coronary Artery Disease
- Coronary Calcific Lesion
- Coronary Stenting
- Echocardiogram, Electrocardiogram
- Echocardiography
- Electrocardiogram
- Endocarditis
- General Cardiology
- Heart Attack/Acute Coronary Syndrome
- Heart Block
- Heart Disease
- High Blood Pressure
- High Cholesterol
- Hyperlipidemia/High Cholesterol
- Hypertension (High Blood Pressure)
- Hypertrophic Cardiomyopathy
- Malignant Hypertension
- Mitral Stenosis
- Mitral Valve Disease
- Myocarditis
- Peripheral Artery Stenting
- Peripheral Vascular Disease
- Peripheral Vascular Ultrasound
- Renal Artery Stenosis
- Stroke
- Valvular Heart Disease
Research
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Wilentz has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.